Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
about
Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgeryPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseUpper gastrointestinal function and glycemic control in diabetes mellitus.Management of diabetic gastroparesis.Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia.GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice.Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans.Low-glycemic load decreases postprandial insulin and glucose and increases postprandial ghrelin in white but not black women.Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells.Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats.Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide.Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP)Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release.Waking up the gut in critically ill patients.Relationships between gastric emptying, postprandial glycemia, and incretin hormonesGastric emptying and glycaemia in health and diabetes mellitus.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Effect of glycemic load on peptide-YY levels in a biracial sample of obese and normal weight women.Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women.Comparative effects of oral and intraduodenal glucose on blood pressure, heart rate, and splanchnic blood flow in healthy older subjects.Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.
P2860
Q26995145-2FA03557-5B84-442D-9520-4E13D97D8A92Q27027920-4F3163E4-1B51-489F-9A42-A85C90BB6413Q33869207-5D011EA6-08E0-4E67-8F55-449EDC8B5519Q34996050-1D29F93C-71BE-4546-9D7E-4480E1B6C2A7Q35195049-25FC7CCD-9BC5-4BE1-9CEB-34CA6E22F2ABQ35227156-71C8FD7F-7E7F-4D62-968F-0C72835D4F3EQ36010043-F72BFF2C-EF0E-456B-938D-DD4D4B5BEB52Q36030179-3C98FFFC-C32A-4802-BEF2-223797BA3ADDQ36081345-65A6B28F-F252-43C3-B057-1451185CE8B7Q36127715-9C3E97DD-D9F8-424E-AF56-4B5280C264B4Q36543063-1BAD27A6-EEDA-45AC-AC53-071C2D40B98BQ36653124-A498592E-A731-4898-A0CF-C86E0FCC56DFQ36755303-7363EFBE-76DF-42BD-A6B1-A6B56C5FED28Q36860222-05AC82C1-6B0F-4343-B9B6-F65C61E2AFF4Q36942072-F8AAD446-154B-4E60-907C-4EF1B07708B3Q37261091-52489871-16B6-48BA-9AB0-EC274DC13D79Q37620091-263C8CD6-3022-4D48-92CD-5F155976DA27Q37771443-0DE25185-C241-40CA-862A-D97EE7C962D9Q37795946-61DBC04F-A985-4508-84F1-947811CCEC05Q38101324-85494109-2BD7-4074-A083-0BAB2CAE46E4Q38271037-21492EC7-D3CC-4013-B222-34927B60B948Q39047697-2A3E049C-3376-43BD-A023-3F843713D54EQ43760615-692A745F-863F-452C-8A31-A32FA1961EEBQ45952549-C353992F-055B-4E86-94C8-C02567A2E544Q45954135-D0773A33-2A4F-46A0-A7BE-832E73F53A9DQ53080088-2D99812C-A9C0-4B30-88F1-42909AAA6096
P2860
Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Initially more rapid small int ...... glycemia in healthy subjects.
@en
Initially more rapid small int ...... glycemia in healthy subjects.
@nl
type
label
Initially more rapid small int ...... glycemia in healthy subjects.
@en
Initially more rapid small int ...... glycemia in healthy subjects.
@nl
prefLabel
Initially more rapid small int ...... glycemia in healthy subjects.
@en
Initially more rapid small int ...... glycemia in healthy subjects.
@nl
P2093
P2860
P1476
Initially more rapid small int ...... glycemia in healthy subjects.
@en
P2093
Christopher K Rayner
Deirdre O'Donovan
Michael Horowitz
Reawika Chaikomin
Selena Doran
P2860
P304
P356
10.1152/AJPENDO.00099.2005
P577
2005-05-10T00:00:00Z